US ETF assets hit record $7.65 trillion in November -State Street Global Advisors
By Suzanne McGee Exchange-traded funds (ETFs) had a bumper month in the United States in November, with assets
1970-01-01 08:00
Suicide Risk From Weight-Loss Drugs Prompts More EU Questions
The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co.
1970-01-01 08:00
Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies
By Patrick Wingrove (Reuters) -Novo Nordisk said on Thursday it sued one compounding pharmacy and refiled a lawsuit against another
1970-01-01 08:00
Altimmune Jumps 66% After Positive Results for Its Obesity Drug
Altimmune Inc. jumped as much as 66% in late trading after the biotech company reported results from a
1970-01-01 08:00
China's factory activity extends declines in November
BEIJING China's manufacturing activity contracted for a second straight month in November and at a quicker pace, an
1970-01-01 08:00
Forget Novo, Rolls-Royce Is Europe’s Best Stock This Year
Rolls-Royce Holdings Plc just extended its status as Europe’s best performing stock this year. The shares rose as
1970-01-01 08:00
Novartis Raises Annual Sales Growth Forecast After Restructuring
Novartis AG raised its mid-term sales growth forecast as the Swiss drugmaker narrows its focus on innovative medicines
1970-01-01 08:00
Hot seat watch: 4 NBA coaches who could be fired this season
With some teams getting off to shaky starts in the season, their coaches' seat is getting warmer. Whether it's now or in the offseason, these coaches could be out of a job.
1970-01-01 08:00
Long-Time Novo Bull Slashes Stake Citing Weight-Loss Drug Hype
A top-performing European fund manager is calling time on “hype” around weight-loss drugs that has sent Novo Nordisk
1970-01-01 08:00
Ozempic Maker Novo Nordisk Invests $2.3 Billion in France Site
Novo Nordisk A/S, which faces supply bottlenecks amid high demand for its blockbuster weight-loss medicines, will invest €2.1
1970-01-01 08:00
Macron to unveil 2.1 billion eur Novo Nordisk pharma investment in France
PARIS French President Emmanuel Macron will on Thursday inaugurate a 2.1 billion euro ($2.3 billion) investment by Danish
1970-01-01 08:00
New ETF Tracks Developers of Obesity Drugs Amid Ozempic Hype
A niche issuer is launching a biotechnology exchange-traded fund whose key holdings include firms benefiting from the hype
1970-01-01 08:00